Telomerase inhibition, telomere shortening, and decreased cell proliferation by cell permeable 2′-O-methoxyethyl oligonucleotides

Zhi Chen, Brett P. Monia, David R. Corey

Research output: Contribution to journalArticle

18 Scopus citations


Telomerase is an attractive target for chemotherapy. Testing this hypothesis will require potent inhibitors with favorable pharmacokinetic properties. We report that 2′-methoxyethyl oligonucleotides complementary to the telomerase RNA component diffuse across cell membranes without the need for cationic carrier lipid, inhibit telomerase, and cause telomeres to shorten. The ability of antitelomerase oligomers to enter cells without the need to add lipid will simplify preclinical studies and may suggest advantages for clinical use.

Original languageEnglish (US)
Pages (from-to)5423-5425
Number of pages3
JournalJournal of Medicinal Chemistry
Issue number25
Publication statusPublished - Dec 5 2002


ASJC Scopus subject areas

  • Organic Chemistry

Cite this